- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有5家主力机构披露2026-06-30报告期持股数据，持仓量总计1.26亿股，占流通A股14.31%
- 波段诊断：
-
技术面诊股
诊断结果：5.7技术面打败了60%的股票
技术面评分前10的股票
近期的平均成本为5.96元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为5.96元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.96","date":1791359561,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2026.10.08","stock":"-1.67","trade":"-1.77","ind":"-2.07"},{"date":"2026.09.30","stock":"0.67","trade":"2.11","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.34","trade":"0.13","ind":"0.34"},{"date":"2026.09.28","stock":"-1.32","trade":"-0.49","ind":"-3.44"},{"date":"2026.09.24","stock":"0.50","trade":"-2.45","ind":"-2.34"},{"date":"2026.09.23","stock":"-1.31","trade":"-0.73","ind":"-0.64"},{"date":"2026.09.22","stock":"-1.61","trade":"0.53","ind":"-0.05"},{"date":"2026.09.21","stock":"1.31","trade":"4.67","ind":"0.65"},{"date":"2026.09.18","stock":"0.49","trade":"0.73","ind":"1.72"},{"date":"2026.09.17","stock":"-0.49","trade":"1.11","ind":"-0.33"},{"date":"2026.09.16","stock":"0.66","trade":"0.58","ind":"1.26"},{"date":"2026.09.15","stock":"-1.78","trade":"-1.55","ind":"-0.72"},{"date":"2026.09.14","stock":"-0.80","trade":"1.85","ind":"-0.64"},{"date":"2026.09.11","stock":"-0.16","trade":"-2.37","ind":"-1.08"},{"date":"2026.09.10","stock":"0.32","trade":"-1.85","ind":"-0.77"},{"date":"2026.09.09","stock":"-1.74","trade":"-1.49","ind":"0.15"},{"date":"2026.09.08","stock":"0.32","trade":"1.50","ind":"-0.52"},{"date":"2026.09.07","stock":"1.12","trade":"0.38","ind":"1.91"},{"date":"2026.09.04","stock":"-0.64","trade":"-0.60","ind":"-0.79"},{"date":"2026.09.03","stock":"-3.23","trade":"-0.47","ind":"0.10"},{"date":"2026.09.02","stock":"0.46","trade":"-1.10","ind":"-1.88"}]
石药景峰,深证成指,化学制药指数
压力支撑
该股压力位为5.95元，支撑位为5.81元。
[{"text":"\u538b\u529b\u4f4d","value":"5.95","date":1791388800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.81","date":1791388800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了79%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月08日 20:30
| 机构今日流向(万元) | -2856.09 | 机构5日流向(万元) | -4194.32 |
| 机构10日流向(万元) | -4292.82 | 机构20日流向(万元) | -13150.65 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加113.82万股，其中基金数没有增加，主力净增仓3家，有一定的中长期投资价值。
截止2026-06-30，共5家主力机构（基金3家，一般法人2家），持仓量总计12590.23万股，占流通A股14.31%
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有113.82万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2025-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：3家 ，持有113.82万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.5消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 原董秘仅任职5个月就辞任，财务部资金经理“接棒”
2026-09-28 - 石药景峰：董事会第九届董事会第六次会议决议公告
2026-09-27 - 石药景峰：叶湘武及其一致行动人持股降至4.93%
2026-09-15 - 石药景峰：2026年第二次临时股东会决议公告
2026-09-08 - 政策支持+AI赋能，医药零售和制造端提质重塑 多家
2026-09-02 - 30家药企集中公布中报:6家净利润翻倍,这家暴增2
2026-08-21 - 股东追踪|姚洁等新进石药景峰前十大流通股东
2026-08-21 - 石药景峰（截止2026年6月30日）股东人数为32
2026-08-20 - 财报速递：石药景峰2026年半年度净利润586.8
2026-08-21 - 石药景峰半年度营业收入2.02亿元，同比增长10.
2026-08-20
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2026-09-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-09-16 |
| 一般消息 | 重大事项 | 关联交易 | 2026-09-09 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-08-18 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2026-08-01 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-30 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-07-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-07-15 |
| 一般消息 | 重大事项 | 关联交易 | 2026-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 利好 | 上市变动 | 公司摘帽 | 2026-06-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-28 |
| 一般消息 | 高管变动 | 因董事会换届 | 2026-04-02 |
| 利好 | 上市变动 | 公司摘* | 2026-03-26 |
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2026-01-24 |
| 利好 | 分红转增 | 10转10股 | 2026-01-13 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-10-27 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2025-10-24 |
| 利空 | 上市变动 | 特别处理*ST | 2025-10-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-09 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 6条 | 0条 | 6条 |
| 利空 | 3条 | 0条 | 3条 |
行业面诊股
诊断结果：7.5行业面打败了95%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.10.08","price":"-2.07","value":"-0.49"},{"date":"2026.09.30","price":"-0.11","value":"-2.45"},{"date":"2026.09.29","price":"0.34","value":"-0.73"},{"date":"2026.09.28","price":"-3.44","value":"0.53"},{"date":"2026.09.24","price":"-2.34","value":"4.67"},{"date":"2026.09.23","price":"-0.64","value":"0.73"},{"date":"2026.09.22","price":"-0.05","value":"1.11"},{"date":"2026.09.21","price":"0.65","value":"0.58"},{"date":"2026.09.18","price":"1.72","value":"-1.55"},{"date":"2026.09.17","price":"-0.33","value":"1.85"},{"date":"2026.09.16","price":"1.26","value":"-2.37"},{"date":"2026.09.15","price":"-0.72","value":"-1.85"},{"date":"2026.09.14","price":"-0.64","value":"-1.49"},{"date":"2026.09.11","price":"-1.08","value":"1.50"},{"date":"2026.09.10","price":"-0.77","value":"0.38"},{"date":"2026.09.09","price":"0.15","value":"-0.60"},{"date":"2026.09.08","price":"-0.52","value":"-0.47"},{"date":"2026.09.07","price":"1.91","value":"-1.10"},{"date":"2026.09.04","price":"-0.79","value":"1.18"},{"date":"2026.09.03","price":"0.10","value":"-1.47"},{"date":"2026.09.02","price":"-1.88","value":"-0.76"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 键凯科技 | 30.00% | 6.32% | 5.3分 |
| 2 | 普洛药业 | 28.10% | 8.26% | 6.5分 |
| 3 | 纳微科技 | 24.84% | -10.45% | 4.7分 |
| 4 | - | 24.00% | -1.54% | 分 |
| 5 | 灵康药业 | 22.74% | 10.30% | 6.7分 |
| 6 | 津药药业 | 22.56% | 10.51% | 5.8分 |
| 8 | 华北制药 | 14.41% | 10.71% | 6.1分 |
| 10 | 海翔药业 | 13.26% | 3.54% | 5.4分 |
| 12 | 丽珠集团 | 11.53% | 6.78% | 6.4分 |
| 14 | 东亚药业 | 9.73% | 3.33% | 4.0分 |
| 16 | 金石亚药 | 9.15% | -1.35% | 5.7分 |
| 18 | 赛分科技 | 8.77% | -11.48% | 6.1分 |
| 20 | 健康元 | 8.55% | 5.21% | 6.5分 |
| 22 | - | 8.19% | 1.52% | 分 |
| 24 | 北陆药业 | 7.49% | -10.79% | 5.7分 |
| 26 | 复星医药 | 7.03% | 2.72% | 6.5分 |
| 28 | 花园生物 | 6.23% | -8.83% | 4.3分 |
| 30 | 鲁抗医药 | 5.98% | 5.03% | 5.9分 |
| 32 | 民生健康 | 5.48% | -0.23% | 6.1分 |
| 34 | 富祥股份 | 5.37% | -8.75% | 4.7分 |
| 36 | ST能特 | 4.94% | -5.90% | 5.5分 |
| 38 | 华海药业 | 4.26% | 1.46% | 6.3分 |
| 40 | 润都股份 | 4.07% | 3.98% | 5.2分 |
| 42 | 富士莱 | 3.93% | 0.15% | 5.4分 |
| 44 | 亨迪药业 | 3.51% | -1.75% | 5.3分 |
| 46 | 共同药业 | 3.14% | -7.44% | 5.4分 |
| 48 | 同和药业 | 2.60% | 1.28% | 5.5分 |
| 50 | 天宇股份 | 2.34% | 3.58% | 5.2分 |
| 52 | 山河药辅 | 2.06% | 0.83% | 5.4分 |
| 54 | ST诺泰 | 1.69% | -0.45% | 5.3分 |
| 56 | 健友股份 | 1.63% | 2.40% | 5.5分 |
| 58 | ST人福 | 1.54% | 1.86% | 5.7分 |
| 60 | 石药创新 | 1.35% | -4.35% | 5.9分 |
| 62 | 金城医药 | 1.05% | -0.07% | 5.7分 |
| 64 | 科源制药 | 0.62% | -8.56% | 4.6分 |
| 66 | 哈三联 | 0.47% | -0.39% | 5.2分 |
| 68 | 仙琚制药 | 0.35% | -1.03% | 5.6分 |
| 70 | 莎普爱思 | 0.34% | 1.54% | 5.7分 |
| 72 | 广济药业 | 0.15% | -0.46% | 5.6分 |
| 74 | 宏辉果蔬 | -0.10% | -9.52% | 4.6分 |
| 76 | 福安药业 | -0.25% | 0.77% | 5.5分 |
| 78 | 汇宇制药 | -0.43% | -9.27% | 5.4分 |
| 80 | 悦康药业 | -0.60% | -4.49% | 4.9分 |
| 82 | 海正药业 | -0.85% | -1.36% | 6.1分 |
| 84 | 新和成 | -1.28% | -0.11% | 5.4分 |
| 86 | 辰欣药业 | -1.63% | -0.28% | 5.3分 |
| 88 | 九典制药 | -1.71% | -1.45% | 5.2分 |
| 90 | 千红制药 | -1.96% | -0.31% | 5.8分 |
| 92 | 海创药业 | -2.14% | -6.18% | 5.4分 |
| 94 | 博瑞医药 | -2.31% | -7.91% | 4.5分 |
| 96 | 罗欣药业 | -2.47% | -0.63% | 5.6分 |
| 98 | 泰恩康 | -2.63% | -15.01% | 4.9分 |
| 100 | - | -2.74% | -0.84% | 分 |
| 102 | 司太立 | -2.95% | -1.04% | 4.6分 |
| 104 | 尔康制药 | -3.00% | -2.71% | 5.0分 |
| 106 | 易明医药 | -3.17% | 1.40% | 5.3分 |
| 108 | 北大医药 | -3.35% | 1.29% | 5.6分 |
| 110 | 莱美药业 | -3.59% | -4.45% | 5.6分 |
| 112 | - | -3.64% | -8.32% | 分 |
| 114 | - | -3.89% | -0.10% | 分 |
| 116 | 宏源药业 | -4.17% | -1.94% | 4.7分 |
| 118 | 诚意药业 | -4.55% | -0.57% | 4.9分 |
| 120 | 向日葵 | -4.81% | -0.67% | 4.1分 |
| 122 | 中哲精化 | -5.11% | -2.30% | 5.6分 |
| 124 | 中关村 | -5.49% | -1.97% | 5.4分 |
| 126 | 立方制药 | -6.30% | -4.45% | 6.1分 |
| 128 | 百济神州 | -6.58% | -5.98% | 5.2分 |
| 130 | 前沿生物 | -6.82% | -9.32% | 5.1分 |
| 132 | 双鹭药业 | -7.11% | -2.77% | 5.0分 |
| 134 | - | -7.97% | -2.99% | 分 |
| 136 | 上海谊众 | -8.57% | -10.45% | 4.2分 |
| 138 | 京新药业 | -8.74% | 0.17% | 5.9分 |
| 140 | 泽璟制药 | -9.16% | -11.00% | 5.0分 |
| 142 | 海思科 | -10.35% | -9.24% | 5.8分 |
| 144 | 海欣股份 | -10.62% | -8.70% | 4.1分 |
| 146 | 广生堂 | -11.08% | -8.15% | 4.2分 |
| 148 | 通化金马 | -12.12% | -6.93% | 4.9分 |
| 150 | - | -12.53% | -12.43% | 分 |
| 152 | 永安药业 | -13.91% | -5.20% | 5.2分 |
| 154 | 冀衡医药 | -18.69% | -2.85% | 4.8分 |
| 156 | 康芝药业 | -20.36% | -2.37% | 4.7分 |
| 158 | 誉衡药业 | -22.08% | -3.02% | 5.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2012-09-10 | 增持 | 增持 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 申银万国 | 2012-09-10 | 增持 | 增持 |
| 国都证券 | 2012-09-10 | 增持 | - |
| 长江证券 | 2012-09-09 | 增持 | 增持 |
更多>>行业资讯
- 2012-09-13科达机电稳步上涨 3大业务或刺激业绩大增
- 2012-09-13二重重装职工董事辞职及增补职工董事
- 2012-09-13凤凰光学修订<公司章程>部分条款
- 2012-09-13南通锻压：使用募集资金对南通锻压设备（天津）有限公
- 2012-09-13华中数控：重大资产重组进展
- 2012-09-13华西能源：获得中国证监会核准公开发行公司债券批复
- 2012-09-13海源机械：持股5%以上股东减持股份
- 2012-09-13中原内配：通过德国DaimlerAG（戴姆勒有限公
- 2012-09-13杰瑞股份：重大事项停牌
- 2012-09-13航天科技：股票交易异常波动
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 111/217 ， 37/217。
[{"date":"2026-06-30","value":"0.56","vol":"-0.11"},{"date":"2026-03-31","value":"0.35","vol":"0.46"},{"date":"2025-12-31","value":"-154.16","vol":"-1.74"},{"date":"2025-09-30","value":"-74.84","vol":"1.58"},{"date":"2025-06-30","value":"-49.70","vol":"1.29"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.56 | 0.35 | -154.16 | -74.84 | -49.70 |
| 行业(%) | -0.11 | 0.46 | -1.74 | 1.58 | 1.29 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"65.17","vol":"49.56"},{"date":"2026-03-31","value":"69.24","vol":"50.37"},{"date":"2025-12-31","value":"62.89","vol":"49.72"},{"date":"2025-09-30","value":"64.64","vol":"49.19"},{"date":"2025-06-30","value":"65.33","vol":"49.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
65.17 | 69.24 | 62.89 | 64.64 | 65.33 |
| 行业(%) | 49.56 | 50.37 | 49.72 | 49.19 | 49.45 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 46/217 ， 24/217。
[{"date":"2026-06-30","value":"10.36","vol":"20.25"},{"date":"2026-03-31","value":"7.42","vol":"24.03"},{"date":"2025-12-31","value":"-9.11","vol":"38.08"},{"date":"2025-09-30","value":"-7.75","vol":"140.73"},{"date":"2025-06-30","value":"-9.47","vol":"78.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
10.36 | 7.42 | -9.11 | -7.75 | -9.47 |
| 行业(%) | 20.25 | 24.03 | 38.08 | 140.73 | 78.18 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"118.02","vol":"366.18"},{"date":"2026-03-31","value":"130.84","vol":"51.69"},{"date":"2025-12-31","value":"-153.11","vol":"-24.28"},{"date":"2025-09-30","value":"8.71","vol":"3.38"},{"date":"2025-06-30","value":"1.47","vol":"65.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
118.02 | 130.84 | -153.11 | 8.71 | 1.47 |
| 行业(%) | 366.18 | 51.69 | -24.28 | 3.38 | 65.15 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 125/217 ， 38/217。
[{"date":"2026-06-30","value":"0.12","vol":"0.21"},{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.43","vol":"0.41"},{"date":"2025-09-30","value":"0.30","vol":"0.30"},{"date":"2025-06-30","value":"0.20","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.06 | 0.43 | 0.30 | 0.20 |
| 行业(次) | 0.21 | 0.10 | 0.41 | 0.30 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.57","vol":"1.27"},{"date":"2026-03-31","value":"0.89","vol":"0.65"},{"date":"2025-12-31","value":"3.38","vol":"2.57"},{"date":"2025-09-30","value":"2.01","vol":"1.93"},{"date":"2025-06-30","value":"1.39","vol":"1.29"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.57 | 0.89 | 3.38 | 2.01 | 1.39 |
| 行业(次) | 1.27 | 0.65 | 2.57 | 1.93 | 1.29 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 141/217 ， 148/217。
[{"date":"2026-06-30","value":"-56.54","vol":"4.77"},{"date":"2026-03-31","value":"-66.52","vol":"-2.17"},{"date":"2025-12-31","value":"27.37","vol":"16.33"},{"date":"2025-09-30","value":"36.07","vol":"4.90"},{"date":"2025-06-30","value":"-15.76","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -56.54 | -66.52 | 27.37 | 36.07 | -15.76 |
| 行业 | 4.77 | -2.17 | 16.33 | 4.90 | 2.94 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"4.87","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.14","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.04","vol":"1.72"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 4.87 | - | 0.14 | - | 0.04 |
| 行业 | 1.32 | 0.00 | 1.60 | 0.00 | 1.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 121/217 ， 128/217。
[{"date":"2026-06-30","value":"5.04","vol":"3.55"},{"date":"2026-03-31","value":"4.47","vol":"3.57"},{"date":"2025-12-31","value":"0.34","vol":"3.38"},{"date":"2025-09-30","value":"0.39","vol":"3.46"},{"date":"2025-06-30","value":"0.19","vol":"3.72"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.04 | 4.47 | 0.34 | 0.39 | 0.19 |
| 行业 | 3.55 | 3.57 | 3.38 | 3.46 | 3.72 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"4.84","vol":"2.85"},{"date":"2026-03-31","value":"4.36","vol":"2.93"},{"date":"2025-12-31","value":"0.28","vol":"2.75"},{"date":"2025-09-30","value":"0.30","vol":"2.72"},{"date":"2025-06-30","value":"0.12","vol":"2.93"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.84 | 4.36 | 0.28 | 0.30 | 0.12 |
| 行业 | 2.85 | 2.93 | 2.75 | 2.72 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 115/217 ， 118/217。
[{"date":"2026-06-30","value":"16.58","vol":"33.40"},{"date":"2026-03-31","value":"18.86","vol":"33.15"},{"date":"2025-12-31","value":"103.45","vol":"34.33"},{"date":"2025-09-30","value":"104.30","vol":"33.76"},{"date":"2025-06-30","value":"105.23","vol":"33.99"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
16.58 | 18.86 | 103.45 | 104.30 | 105.23 |
| 行业(%) | 33.40 | 33.15 | 34.33 | 33.76 | 33.99 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.19","vol":"0.71"},{"date":"2026-03-31","value":"0.23","vol":"9.70"},{"date":"2025-12-31","value":"36.65","vol":"1.75"},{"date":"2025-09-30","value":"24.55","vol":"1.18"},{"date":"2025-06-30","value":"19.32","vol":"0.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.19 | 0.23 | 36.65 | 24.55 | 19.32 |
| 行业(%) | 0.71 | 9.70 | 1.75 | 1.18 | 0.87 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-1.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.36","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-0.81","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]